🔎 Trials Near Me

Utama › Penyakit Paru-paru › Massachusetts › Boston

Kajian klinikal Penyakit Paru-paru di Boston, MA

14 kajian untuk Penyakit Paru-paru sedang mencari peserta di lokasi dalam dan sekitar Boston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Mengambil pesertaFasa 3
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06765109

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Mengambil pesertaFasa 3
  • Brigham and Women's Hospital, Boston
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

Mengambil pesertaFasa 3
  • Brigham and Women's Hospital, Boston
  • Clinical Trials Center, Boston
  • Clinical Trials Hub, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07013474

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Mengambil pesertaFasa 2
  • Brigham and Women's Hospital, Boston
Umur 40 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07759245

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Mengambil pesertaFasa 1/2
  • Dana Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Boston Medical Center, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Mengambil pesertaFasa 2
  • Clinical Research Site, Boston
Umur 18 hingga 85 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07333183

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

Mengambil pesertaFasa 2
  • Beth Israel Deaconess Medical Center, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT05967689

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Mengambil pesertaFasa 2
  • Dana-Farber Cancer Institute, Boston
  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jun 2026 · NCT05922761

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Mengambil pesertaFasa 1/2
  • Massachusetts General Hospital,, Boston
Umur 12 ke atas · Semua jantina · Dikemas kini 27 Mei 2026 · NCT03093116

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Mengambil peserta
  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Feb 2026 · NCT02984761

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Mengambil pesertaFasa 2
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Dis 2025 · NCT06619561

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

Mengambil peserta
  • Brigham and Women's Hospital, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2025 · NCT04555161

Kajian Penyakit Paru-paru di bandar lain

Kajian lain di Boston

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.